Asambly Chemicals Co. Ltd.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsActive Pharmaceutical Ingredients

Ticagrelor AZD - 6140 CAS 274693 27 5 GMP DMF C23H28F2N6O4S

I'm Online Chat Now

Ticagrelor AZD - 6140 CAS 274693 27 5 GMP DMF C23H28F2N6O4S

China Ticagrelor AZD - 6140 CAS 274693 27 5 GMP DMF C23H28F2N6O4S supplier

Large Image :  Ticagrelor AZD - 6140 CAS 274693 27 5 GMP DMF C23H28F2N6O4S

Product Details:

Place of Origin: China

Payment & Shipping Terms:

Minimum Order Quantity: 1KG
Packaging Details: Drum
Contact Now
Detailed Product Description
Name: Ticagrelor Synonym: AZD - 6140
CAS: 274693-27-5 Molecular Formula: C23H28F2N6O4S
High Light:

274693 27 5

,

1377049 84 7

Ticagrelor AZD - 6140 CAS : 274693-27-5 GMP DMF

 

Name : Ticagrelor

 

CAS No . : 274693-27-5

 

Synonym : AZD - 6140

 

Chemical Name : ( 1, 2, 3, 5) - 3 - [ 7 - [ ( 1, 2) - 2 - ( 3 , 4 - Difluorophenyl ) cyclopropylamino ] - 5 - ( propylthio ) - 3- [ 1 , 2 , 3 ] triazolo [ 4 , 5-] pyrimidin - 3 - yl ] - 5 - ( 2 - hydroxyethoxy ) cyclopentane - 1 , 2 - diol

 

Molecular Formula : C23H28F2N6O4S

 

Molecular Weight : 522.57

 

Description : 

 

Ticagrelor is the active pharmaceutical ingredients (API) of branded drug Brillinta, Briliquie and Possia. It was approved in December 3 2010 in Euorpe and in July 2011in USA by FDA . It is marketed by AstraZeneca. Ticagrelor is a platelet aggregation inhibitor and used to prevent thrombotic events such as stroke or heart attack in people with acutate coronary syndrome or myocardial infarction with ST elevation. Ticagrelor is better than clopidogrel for P2Y12 inhibition treatment in patients with NSTE-ACS treated with early invasive strategy and/or coronary stenting according to AHA/ACC Guidelines (09/2014).

 

The drug might be protected by patents in some courtires or areas. We only sell it to non patent protected countries or areas. The sale to patent protection countries and areas is only for R & D purpose. The buyers should take all responsiblity of patent status in his countries or areas.

 

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.

 

Contact Details
Asambly Chemicals Co. Ltd.

Contact Person: MAO Xiaolong

Send your inquiry directly to us (0 / 3000)